Intelligencia

Intelligenica is a New York City-based company that has used artificial intelligence and machine learning to build a platform which can be utilized to reduce the risks that come when developing drugs. It estimates the risk of clinical trials and interprets the multitude of factors that contribute to that risk.

The cloud-based platform is intended to be used for decision making in various areas of drug development, such as clinical development, portfolio strategy, and business development. It has been used in industries such as pharmaceuticals and biotechnology. The company has a data cube that is referred to at iNsight and it integrates structured and unstructured data from a host of data sources. The data comes from clinical trial design, clinical outcomes, regulatory pathways, and company characteristics and can be used to predict the probability of technical and regulatory success of a drug or therapeutic. It can also be used by scientists and business development professionals to identify a drug's potential and the value that would come from researching and developing it.